Graft-versus-Host Disease (GVHD) is the primary cause of late morbidity and mortality after
allogeneic stem cell transplantation (SCT). In chronic GVHD (cGVHD), often multiple organ …

Graft-versus-host disease (GvHD) is a serious complication of allogeneic hematopoietic cell
transplantation causing significant morbidity and mortality. Corticosteroids are the …

Abstract Background and Summary: Extracorporeal photopheresis (ECP) is a leukapheresis-
based procedure used in the therapy of acute and chronic graft-versus-host disease …

Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …

Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …

Improvement in chronic graft vs. host disease (cGvHD) following treatment with
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …

Introduction Although extracorporeal photopheresis (ECP) is a promising second-line
therapy in the treatment of chronic graft-versus-host disease (cGVHD), its use is limited by its …

Chronic Graft versus Host Disease (cGvHD) is an important cause of late non-relapse
morbidity and mortality following allogeneic hemopoietic stem cell transplantation (allo …

Background/Objectives: Despite novel biological agents, steroid-dependent or-refractory
graft-versus-host disease (GvHD) remains a severe complication of allogeneic …

DB and DK contributed to the work equally. Background Extracorporeal photopheresis
(ECP) is a recommended second or later line of therapy for chronic GVHD (cGVHD), and is …